Practical assessment of maternal cardiovascular risk in pregnancy

Congenital Heart Disease

Volumn 3, Issue 5, 2008, Pages 308-316

  Moghbeli, Nazanin ^a   Pare, Emmanuelle ^a   Webb, Gary ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Pregnancy; Risk assessment; Structural heart disease

Indexed keywords

HEPARIN; WARFARIN;

ANAMNESIS; AORTA RUPTURE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CESAREAN SECTION; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CYANOSIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EISENMENGER COMPLEX; ELECTROCARDIOGRAPHY; EXERCISE TEST; FETUS CIRCULATION; FETUS DEATH; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART FAILURE; HEART HEMODYNAMICS; HEART SURGERY; HIGH RISK PATIENT; HUMAN; MATERNAL MORTALITY; MITRAL VALVE STENOSIS; MONOTHERAPY; NEWBORN MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREDICTION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; UTERUS CONTRACTION; VAGINAL DELIVERY; VALSALVA MANEUVER; VALVULAR HEART DISEASE;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS;

EID: 52649124260     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2008.00207.x     Document Type: Article

References (49)

1. Van Mook WN, Peeters L. Severe cardiac disease in pregnancy, part I: hemodynamic changes and complaints during pregnancy, and general management of cardiac disease in pregnancy. Curr Opin Crit Care. 2005;11:430-434.
2. De Swiet M. Maternal mortality: Confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol. 2000;182:760-766.
3. Duvekot JJ, Peeters LL. Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv. 1994;49:830-839.
4. Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J. 1997;133:53-59.
5. Stout KK, Otto CM. Pregnancy in women with valvular heart disease. Heart. 2007;93:552-558.
6. Colman JM, Silversides CK, Sermer M, Siu SC. Cardiac monitoring during pregnancy. In: Steer PJ, Gatzoulis MA, Baker P, eds. Cardiac Monitoring During Pregnancy. London: The Royal College of Obstetricians and Gynaecologists;2006:67.
7. Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96:2789-2794.
8. Siu SC, Sermer M, Colman JM, etal. Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515-521.
9. Campos O, Andrade JL, Bocanegra J, etal. Physiologic multivalvular regurgitation during pregnancy: A longitudinal Doppler echocardiographic study. Int J Cardiol. 1993;40:265-272.
10. ACOG Committee on Obstetric Practice. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol. 2004;104:647-651.
11. Kanal E, Barkovich AJ, Bell C, etal. ACR guidance document for safe MR practices: 2007. Am J Roentgenol. 2007;188:1447-1474.
12. Oosterhof T, Vriend JW, Spijkerboer AM, Mulder BJ. Cardiovascular magnetic resonance in a pregnant patient with absent pulmonary valve syndrome. Int J Card Imaging. 2007;23:249-252.
13. Whittemore R, Hobbins JC, Engle MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol. 1982;50:641-651.
14. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: Comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835.
15. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006;113:517-524.
16. Chia P, Raman S, Tham SW. The pregnancy outcome of acyanotic heart disease. J Obstet Gynaecol Res. 1998;24:267-273.
17. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol. 2007;49:2303-2311.
18. Siu S, Colman JM. Cardiovascular problems and pregnancy: An approach to management. Cleve Clin J Med. 2004;71:977-985.
19. Zuber M, Gautschi N, Oechslin E, Widmer V, Kiowski W, Jenni R. Outcome of pregnancy in women with congenital shunt lesions. Heart. 1999;81:271-275.
20. Connolly HM, Warnes CA. Ebstein's anomaly: Outcome of pregnancy. J Am Coll Cardiol. 1994;23:1194-1198.
21. Drenthen W, Pieper PG, Ploeg M, etal. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J. 2005;26:2588-2595.
22. Guedes A, Mercier LA, Leduc L, Berube L, Marcotte F, Dore A. Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol. 2004;44:433-437.
23. Connolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol. 1999;33:1692-1695.
24. Therrien J, Barnes I, Somerville J. Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol. 1999;84:820-824.
25. Canobbio MM, Mair DD, Van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 1996;28:763-767.
26. Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy. Chest. 2001;119:973-975.
27. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650-1657.
28. Arias F, Pineda J. Aortic stenosis and pregnancy. J Reprod Med. 1978;20:229-232.
29. Easterling TR, Chadwick HS, Otto CM, Benedetti TJ. Aortic stenosis in pregnancy. Obstet Gynecol. 1988;72:113-118.
30. Lao TT, Sermer M, MaGee L, Farine D, Colman JM. Congenital aortic stenosis and pregnancy-a reappraisal. Am J Obstet Gynecol. 1993;169:540-545.
31. Silversides CK, Colman JM, Sermer M, Farine D, Siu SC. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91:1386-1389.
32. Yap S, Drenthen W, Pieper PG, etal. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol. 2008;126:240-246.
33. Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893-899.
34. Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol. 2003;91:1382-1385.
35. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med. 2000;160:191-196.
36. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy. Circulation. 2003;107:1240-1246.
37. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-1188.
38. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J. 1991;121:1776-1778.
39. Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol. 1997;176:189-195.
40. Ceci O, Berardesca C, Caradonna F, Corsano P, Guglielmi R, Nappi L. Recurrent peripartum cardiomyopathy. Eur J Obstet Gynecol Reprod Biol. 1998;76:29-30.
41. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111:2050-2055.
42. Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol. 2003;102:1326-1331.
43. Thaman R, Varnava A, Hamid MS, etal. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart. 2003;89:752-756.
44. Immer FF, Bansi AG, Immer-Bansi AS, et al. Aortic dissection in pregnancy: Analysis of risk factors and outcome. Ann Thorac Surg. 2003;76:309-314.
45. Pyeritz RE. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med. 1981;71:784-790.
46. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173:1599-1606.
47. Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: Outcome of pregnancy. J Am Coll Cardiol. 2001;38:1728-1733.
48. Siu SC, Colman JM, Sorensen S, etal. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation. 2002;105:2179-2184.
49. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89:2673-2676.